ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

HHS News: Shalala To Form Genetic Testing Advisory Committee

August 14, 1998

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

May 17, 1996

Revive Comprehensive Program, But Don’t Tie It to Grant Review, Center Executive Agrees

July 29, 1988

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

South Carolina Politicos Join Hollings Oncology Center Section

October 30, 1992

Scientists Brief Writers On Progress In Cancer Research

April 11, 1975